SHELL ASSET MANAGEMENT CO - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$106
-99.9%
2,644
-18.4%
0.01%
+25.0%
Q3 2022$104,000
-14.0%
3,240
-20.6%
0.00%0.0%
Q2 2022$121,000
+6.1%
4,081
+0.3%
0.00%
+33.3%
Q1 2022$114,000
-47.0%
4,069
-12.8%
0.00%
-25.0%
Q4 2021$215,000
+40.5%
4,668
+0.3%
0.00%
+33.3%
Q3 2021$153,000
-9.5%
4,652
-3.5%
0.00%0.0%
Q2 2021$169,000
+2.4%
4,822
+5.7%
0.00%0.0%
Q1 2021$165,0004,5620.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders